Please login to the form below

Not currently logged in
Email:
Password:

Otmar Wiestler appointed to Bayer supervisory board

He replaces Klaus Kleinfeld

edit-Otmar-D-WiestlerGermany-based Bayer has appointed Otmar Wiestler to its supervisory board with immediate effect.

Since January 2004 Wiestler has been chairman of Bayer's management board and scientific director of the German cancer research centre in Heidelberg, Germany. He has also been chairman of the advisory committee and a member of the board of German Cancer Aid.

In addition to these roles, he served in the executive committee of the Helmholtz Association from 2007 to 2012.

Wiestler succeeds Klaus Kleinfeld, who left the position in September in order to concentrate on other office and honorary posts, some of which are located in the US.

In regards to the appointment, Werner Wenning, chairman of Bayer's supervisory board, said: “We would like to thank Mr Kleinfeld for our very successful and trusting cooperation. In Prof Wiestler we have found a competent successor with extensive scientific expertise.”

9th October 2014

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Future Market Insights

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...

Infographics